Vermont lawmakers OK doc-assisted suicide

The state will become the first to use a legislative vote to legalize physician-assisted suicide after the governor, who has expressed his support for the measure, signs the bill.

The Wall Street Journal: Lawmakers in Vermont Approve Assisted Suicide
Vermont is poised to become the third state in the nation to allow physicians to prescribe lethal drugs to terminally ill patients who want to die. State lawmakers on Monday night approved an assisted-suicide bill, which now awaits the signature of Gov. Peter Shumlin, a first-term Democrat who has said he would sign it, likely within a week. Once enacted, Vermont would be the first state to decriminalize assisted suicide through a legislative vote (Gershman, 5/14).

Politico: Vermont OKs Assisted Suicide Bill
The approval of an assisted suicide bill in Vermont brings to a close a 10-year battle in the state over the issue and delivers the third state-level victory for advocates seeking to advance the policy nationwide. But the national implications for the bill -- which won legislative approval Monday night and allows doctors to prescribe lethal doses of drugs to some terminally ill patients -- are tough to pinpoint (Cheney, 5/15).

Medpage Today: Vermont Passes Assisted Suicide Bill
Vermont will soon become the fourth state to allow physician-assisted suicide now that state lawmakers there have passed a bill allowing the practice. The bill, the Patient Choice and Control at End of Life Act, next heads to the desk of Gov. Peter Shumlin (D), who is expected to sign the bill into law, having previously expressed his support for it. Taking effect July 1, the law would absolve healthcare professionals licensed in the state of civil or criminal liability if a terminally ill patient self-administers a lethal dose of a drug meant to treat their condition. The physician is required to have examined the patient, who must be expected to live no more than 6 months (Pittman, 5/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Do GLP-1 drugs cause cancer? New review says no, may even protect